Medicare Enrolled
Dr. Christopher Tully
Hematology & Oncology · Mountain Lakes, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tully from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tully?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tully
Dr. Christopher Tully is a hematology & oncology specialist in Mountain Lakes, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Tully performed 28,508 Medicare services across 1,795 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tully received a total of $19,825 from 85 pharmaceutical and/or device companies across 1281 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tully is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 26% volume in NJ
$19,825 industry payments
Medicare Practice Summary
Medicare Utilization ↗28,508
Medicare services
Top 26% in NJ for hematology & oncology
1,795
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,584 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Monoferric) | 8,900 | $17 | $50 |
| Denosumab injection (Prolia/Xgeva) | 3,720 | $19 | $40 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,440 | $6 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,280 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,590 | $1 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,445 | $108 | $225 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,394 | $8 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,372 | $8 | $40 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
775 | $23 | $100 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
511 | $12 | $50 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
369 | $122 | $350 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
304 | $14 | $75 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
286 | $27 | $125 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
168 | $104 | $175 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
152 | $1 | $10 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
131 | $43 | $75 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
124 | $65 | $125 |
| New patient office visit, complex (60-74 min) | 123 | $191 | $500 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
117 | $1 | $2 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
93 | $59 | $200 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
82 | $61 | $200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $51 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
33 | $151 | $275 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
32 | $71 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $160 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
34.1% high complexity
46.4% medium
19.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,825
Total received (2018-2024)
Avg $2,832/year across 7 years
Top 14% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
85
Companies
1,281
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,612 (88.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,220 (6.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$993 (5.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,993
2023
$2,006
2022
$1,696
2021
$2,980
2020
$2,270
2019
$4,549
2018
$4,332
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$313
E.R. Squibb & Sons, L.L.C.
$177
Incyte Corporation
$136
Novartis Pharmaceuticals Corporation
$132
Janssen Biotech, Inc.
$116
GlaxoSmithKline, LLC.
$90
Daiichi Sankyo Inc.
$89
PFIZER INC.
$66
ABBVIE INC.
$65
Mirati Therapeutics, Inc.
$64
Ipsen Biopharmaceuticals, Inc
$57
Merck Sharp & Dohme LLC
$56
Bayer Healthcare Pharmaceuticals Inc.
$45
Genmab U.S., Inc.
$43
TAIHO ONCOLOGY, INC.
$42
Blueprint Medicines Corporation
$37
Myriad Genetic Laboratories, Inc.
$35
Kyowa Kirin, Inc.
$33
Genentech USA, Inc.
$32
Regeneron Healthcare Solutions, Inc.
$32
Pharmacosmos Therapeutics Inc.
$30
Tempus AI, Inc
$25
Celltrion USA Inc.
$24
Gilead Sciences, Inc.
$22
Legend Biotech USA Inc.
$19
BeiGene USA, Inc.
$18
Astellas Pharma US Inc
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Exelixis Inc.
$17
ARRAY BIOPHARMA INC
$17
Adaptive Biotechnologies Corporation
$17
Celgene Corporation
$17
PUMA BIOTECHNOLOGY, INC.
$17
Amgen Inc.
$17
Lilly USA, LLC
$15
Eisai Inc.
$14
ImmunoGen, Inc.
$14
Aveo Pharmaceuticals, Inc.
$13
Top 3 companies account for 31.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,725
E.R. Squibb & Sons, L.L.C.
$1,528
Seagen Inc.
$1,479
Genentech USA, Inc.
$1,368
Amgen Inc.
$1,096
Novartis Pharmaceuticals Corporation
$1,090
Merck Sharp & Dohme Corporation
$1,068
Janssen Biotech, Inc.
$1,029
Incyte Corporation
$875
Bayer HealthCare Pharmaceuticals Inc.
$411
Daiichi Sankyo Inc.
$397
Celgene Corporation
$396
GlaxoSmithKline, LLC.
$385
Astellas Pharma US Inc
$372
Lilly USA, LLC
$310
Puma Biotechnology, Inc.
$299
GENZYME CORPORATION
$299
PFIZER INC.
$287
Ipsen Biopharmaceuticals, Inc
$283
AbbVie, Inc.
$271
Gilead Sciences, Inc.
$261
Pharmacyclics LLC, An AbbVie Company
$260
Regeneron Healthcare Solutions, Inc.
$251
EISAI INC.
$214
Foundation Medicine, Inc.
$190
Eisai Inc.
$189
Takeda Pharmaceuticals U.S.A., Inc.
$185
Seattle Genetics, Inc.
$171
Kyowa Kirin, Inc.
$165
Mirati Therapeutics, Inc.
$161
Verastem, Inc.
$142
Merck Sharp & Dohme LLC
$129
Celltrion USA Inc.
$129
Boehringer Ingelheim Pharmaceuticals, Inc.
$119
Bayer Healthcare Pharmaceuticals Inc.
$105
BeiGene USA, Inc.
$104
Myriad Genetic Laboratories, Inc.
$96
ABBVIE INC.
$93
Kite Pharma, Inc.
$91
Exelixis Inc.
$88
Blueprint Medicines Corporation
$87
AbbVie Inc.
$85
CTI BioPharma Corp.
$72
Alexion Pharmaceuticals, Inc.
$72
AMAG Pharmaceuticals, Inc.
$64
Clovis Oncology, Inc.
$62
Pharmacosmos Therapeutics Inc.
$60
EMD Serono, Inc.
$59
Taiho Oncology, Inc.
$58
Karyopharm Therapeutics Inc.
$58
Janssen Pharmaceuticals, Inc
$58
Genmab U.S., Inc.
$57
Rigel Pharmaceuticals, Inc.
$56
Teva Pharmaceuticals USA, Inc.
$55
Partner Therapeutics, Inc.
$51
Adaptive Biotechnologies Corporation
$47
PharmaEssentia USA Corporation
$44
Epizyme, Inc.,
$43
ImmunoGen, Inc.
$43
TAIHO ONCOLOGY, INC.
$42
Myovant Sciences Inc.
$38
Spectrum Pharmaceuticals Inc.
$34
TESARO, Inc.
$32
Jazz Pharmaceuticals Inc.
$31
ARRAY BIOPHARMA INC
$30
Aveo Pharmaceuticals, Inc.
$29
SUN PHARMACEUTICAL INDUSTRIES INC.
$28
EUSA Pharma (US) LLC
$26
AVEO Pharmaceuticals, Inc.
$26
Tempus AI, Inc
$25
G1 Therapeutics, Inc.
$24
Biocon Biologics Inc
$19
Legend Biotech USA Inc.
$19
Servier Pharmaceuticals LLC
$18
PUMA BIOTECHNOLOGY, INC.
$17
MorphoSys, US Inc.
$16
JAZZ PHARMACEUTICALS INC.
$15
Heron Therapeutics, Inc.
$15
TG THERAPEUTICS, INC.
$15
Dendreon Pharmaceuticals LLC
$15
Acceleron Pharma, Inc.
$15
Agios Pharmaceuticals, Inc.
$14
Horizon Therapeutics plc
$14
Pharmacyclics LLC, an AbbVie Company
$14
Lexicon Pharmaceuticals, Inc.
$13
Top 3 companies account for 23.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Copiktra · Creon · DARZALEX · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · EVENITY · Elahere · Enhertu · Epkinly · Erleada · FARESTON · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCREVUS · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Perjeta · Polivy · Poteligeo · Prolia · REBLOZYL · ROLVEDON · RYDAPT · Reblozyl · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Trodelvy · UKONIQ · ULTOMIRIS · VEGZELMA · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · YONSA · Yescarta · ZEJULA · ZYTIGA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
170
Per 100K population
33.3
County median income
$134,929
Nearest hospital
SAINT CLARE'S HOSPITAL/ DENVILLE CAMPUS
2.4 mi
2.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tully is a mixed practice specialist, with above-average Medicare volume (top 26% in NJ), with low-engagement industry engagement in the top 14% of NJ peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tully experienced with iron infusion (monoferric)?
Based on Medicare claims data, Dr. Tully performed 8,900 iron infusion (monoferric) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tully receive payments from pharmaceutical companies?
Yes. Dr. Tully received a total of $19,825 from 85 companies across 1,281 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tully's costs compare to other hematology & oncology specialists in Mountain Lakes?
Dr. Tully's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tully) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Mountain Lakes
Browse hematology & oncology specialists in Mountain Lakes ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology